Presentation TCT 2014 Are There Meaningful Differences in Vascular Responses Between the Different Classes of Metallic Stent Technologies? Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Francesco Prati September 15, 2014
Presentation TCT 2014 FOCUS np: Clinical and Angiographic Results with a Nanoparticle-Based Siroliumus-Eluting Stent and Balloon Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Upendra Kaul September 15, 2014
Presentation TCT 2014 BioFreedom: From Pilot Results to the Leaders-Free Trial Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Philip M. Urban September 15, 2014
Presentation TCT 2014 Amphillic Sirolimus-Eluting Cre8 Technology - New Studies and Future Directions Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca September 15, 2014
Presentation TCT 2014 The Drug-Filled Stent: From Concept to Clinical Development Presenter: Robert A. Byrne, Didier Carrié, Giuseppe De Luca, Martin T. Rothman September 15, 2014
Presentation TCT 2014 TCT 599: Final Procedural, 30-Day and 6-Month Angiographic, Clinical, and OCT Outcomes from the DIRECT II Trial Using the Svelte Integrated Delivery System with Enzymatic Bioabsobable Sirolimus Coating Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Stefan Verheye September 15, 2014
Presentation TCT 2014 Is Pro-healing a Valid Concept? The Sirolimus-Endothelial Progenitor Cell Antibody Combo Technology Presenter: Marie-Claude Morice, Giulio G. Stefanini, Pedro A. Lemos, Michael Haude September 15, 2014
Presentation TCT 2014 The Sirolimus-Eluting Stent-Balloon: Update of the Abluminus ABL-1 Study Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Sameer I. Dani September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms VII: MiStent Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, John A. Ormiston September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms VI: Ultimaster Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Shigeru Saito September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms V: Alex Eluting Stent Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms IV: Firehawk Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Bo Xu September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms III: Inspiron Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Pedro A. Lemos September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms II: ORSIRO Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker September 15, 2014
Presentation TCT 2014 Cobalt-Chromium Sirolimus-Eluting Platforms I: BioMime Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ricardo A. Costa September 15, 2014
Presentation TCT 2014 Novolimus-Eluting from a Bioabsorbable Polymer: Latest Update from EXCELLA II Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stefan Verheye September 15, 2014
Presentation TCT 2014 Platinum-Chromium Platform with Reduced Polymer Load and Rapid Bioabsorption: Everolimus-Eluting SYNERGY Program Update Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Ian T. Meredith September 15, 2014
Presentation TCT 2014 TCT 584: Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus Durable Polymer, Everolimus-Eluting Stent: 3-Year Follow-up from the COMPARE II Trial Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil September 15, 2014
Presentation TCT 2014 TCT 652: Incidence and Predictors of Late Catch-up Phenomenon After Drug-Eluting Stent Implantation Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Masanobu Ohya September 15, 2014
Presentation TCT 2014 Safety and Efficacy Profile of BioMatrix and Nobori in Simple and Complex Lesions: Global Program Overview Presenter: Alexandre Abizaid, Pieter C. Smits, Robert J. Gil, Stephan Windecker September 15, 2014